科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
专利缴费
专利查询
未登录
返回
期刊详情
P
Pediatric Drugs
IF
3.3
论文数
849
被引数
2077
相关解读
0
订阅
期刊论文
849
相关解读
0
期刊论文
849
发表时间
发表时间
IF
被引数
Unintentional Incorrect Route of Drug Administration: An Analysis of Spontaneous Reports of Medication Errors in Children and Adolescents from Germany
非故意药物给药途径错误:对来自德国的儿童和青少年用药错误自发报告的分析
Pediatric Drugs
IF
3.3
2026-10-23
0
OA
AI
Severin Domgörgen; Claudia Kayser; Irmgard Toni; Armin Ströbel; Antje Neubert; Bernhardt Sachs; Diana Dubrall
分享
收藏
Management of Pediatric Chronic Spontaneous Urticaria: Current Evidence and Emerging Therapies
儿童慢性自发性荨麻疹的管理:当前证据和新兴疗法
Pediatric Drugs
IF
3.3
2026-10-22
0
OA
AI
Micol Tedeschi; Maria Gnarra Buethe; Gian Luigi Marseglia; Amelia Licari
分享
收藏
Eight-Year Trends in Nationwide Proton Pump Inhibitor Use Among Finnish Children Under 6 Years by Sector and Specialty
全国范围内芬兰6岁以下儿童质子泵抑制剂使用八年趋势分析:按部门和专科划分
Pediatric Drugs
IF
3.3
2026-10-22
0
OA
AI
Laura Räisänen; Péter Csonka; Juho Leppänen; Hanna Koskinen; Heini Kari
分享
收藏
Isavuconazole: Real-World Data and Clinical Considerations for Pediatric Patients
伊曲康唑:真实世界数据及儿科患者的临床考量
Pediatric Drugs
IF
3.3
2026-10-16
0
OA
AI
Lorenzo Chiusaroli; Danila Seidel; Daniel Ebrahimi-Fakhari; Luise Martin; Karoline Ehlert; Andreas H. Groll; Zoi Dorothea Pana
分享
收藏
Pharmacological Interventions for Acute Stress Disorder and for the Prevention and Treatment of Post-traumatic Stress Disorder in Children and Adolescents: A Narrative Review
针对儿童和青少年急性应激障碍的药物干预以及预防与治疗创伤后应激障碍:一项叙事性综述
Pediatric Drugs
IF
3.3
2026-10-15
0
PRE
AI
Charles Tesnières; Hala Kerbage; Eric Bui; Julie Rolling
分享
收藏
Efficacy of Ibuprofen Versus Acetaminophen for Acute Fever Management in Febrile Children: A Systematic Review and Meta-analysis of Randomized Controlled Trials
布洛芬与对乙酰氨基酚在发热儿童急性发热管理中的疗效比较:一项随机对照试验的系统评价与Meta分析
Pediatric Drugs
IF
3.3
2026-10-13
0
PRE
AI
Gian Luigi Marseglia; Paola Giovanna Marchisio; Gregorio Paolo Milani; Michele Miraglia del Giudice; Irene Schiavetti; Giorgio Ciprandi
分享
收藏
Correction: Effectiveness and Safety of IL‑17A Inhibitors in Pediatric Psoriasis: A Real‑World, Multicenter, International Study
更正:IL‑17A 抑制剂在儿童银屑病中的有效性与安全性:一项真实世界、多中心、国际性研究
Pediatric Drugs
IF
3.3
2026-10-13
0
PRE
AI
Vito Di Lernia; Bertille Bonniaud; Eve Puzenat; Christine Bodemer; Morgane Seyler; Marieke M. B. Seyger; Mathilde Tardieu; Helena Iznardo; Francesca Satolli; Paula C. Luna; Olivier Carpentier; Ouafa Hocar; Tiago Torres; Iria Neri; Luca Stingeni; Cristina Bertoli; Alain Beauchet; Emmanuel Mahé
分享
收藏
Exclusion by Design: Regulatory Reform and Evolving Frameworks for Clinical Trials in Pregnancy
设计中的排除:妊娠期临床试验的监管改革与演变框架
Pediatric Drugs
IF
3.3
2026-09-30
0
OA
AI
Gregory L. Kearns; Agnes Saint-Raymond
分享
收藏
Current Management and Emerging Therapies for Pediatric Vitiligo: A Narrative Review
儿童白癜风当前管理和新兴疗法:一篇叙事性综述
Pediatric Drugs
IF
3.3
2026-09-22
0
PRE
AI
Jade Howard; William Fitzmaurice; Aleena Boby; Benjamin Levin; Nanette Silverberg
分享
收藏
Repeated-Dose High-Dose Ivermectin Pharmacokinetics and Safety in Children with Acute Dengue
重复给药高剂量伊维菌素在急性登革热儿童中的药代动力学与安全性
Pediatric Drugs
IF
3.3
2026-09-22
0
OA
AI
Keswadee Lapphra; Dumrong Mairiang; Joel Tarning; Dararat Prayongkul; Chunya Puttikhunt; Adisak Songjaeng; Tanapan Prommool; Nattaya Tangthawornchaikul; Kulkanya Chokephaibulkit; Panisadee Avirutnan
分享
收藏
Real-World Outcomes of Ocrelizumab and Ofatumumab Treatment in Pediatric-Onset Multiple Sclerosis
奥瑞利珠单抗和奥法木单抗治疗儿童期发病多发性硬化的真实世界结局
Pediatric Drugs
IF
3.3
2026-09-21
0
PRE
AI
Vivien X. Xie Cherng; Claire Har; Hayley Roper; Alexandra B. Kornbluh; Ilana Kahn
分享
收藏
Managing Sjögren’s Disease in Pediatric Patients
儿科患者干燥综合征的管理
Pediatric Drugs
IF
3.3
2026-09-21
0
PRE
AI
Sara M. Stern; Ludovic Trinquart; Hermine I. Brunner; Marisha E. Palm; Nora G. Singer
分享
收藏
Authors' Reply to Kaplan Comment on “Safety and Efficacy of Oral Ferric Maltol and Ferrous Sulfate for Iron Deficiency Anemia in Infants, Children and Adolescents: A Multicenter Randomized Trial”
作者对Kaplan就“口服麦芽酚铁和硫酸亚铁对婴儿、儿童和青少年缺铁性贫血的安全性与有效性:一项多中心随机试验”的评论的回复
Pediatric Drugs
IF
3.3
2026-09-18
0
PRE
AI
Richard K. Russell
分享
收藏
Comment on “Safety and Efficacy of Oral Ferric Maltol and Ferrous Sulfate for Iron Deficiency Anemia in Infants, Children and Adolescents: A Multicenter Randomized Trial”
对“口服麦芽酚铁和硫酸亚铁治疗婴儿、儿童和青少年缺铁性贫血的安全性与有效性:一项多中心随机试验”的评论
Pediatric Drugs
IF
3.3
2026-09-18
0
PRE
AI
Fatih Kaplan
分享
收藏
How Organ Manifestations Beyond the Bone May Guide Risk Stratification and Treatment Decisions in Chronic Nonbacterial Osteomyelitis
慢性非细菌性骨髓炎中,超出骨骼的器官表现如何指导风险分层和治疗决策
Pediatric Drugs
IF
3.3
2026-09-15
0
OA
AI
Giulia Inguscio; Anja Schnabel; Eve Roberts; Christian M. Hedrich
分享
收藏
Model-Informed Precision Dosing in Pediatric Patients: Current Software Tools and Bedside Guided Application
基于模型的精准给药在儿科患者中的应用:当前软件工具和床边指导应用
Pediatric Drugs
IF
3.3
2026-08-21
0
PRE
AI
Abdullah Aljutayli; Emna Gaies; Mohammed S. Alasmari; Zekra Kamel Aljehani; Abrar Samman; Sara Abudahab; Manal Abouelkheir; Abdullah Alsultan
分享
收藏
AFREZZA® (Insulin Human) Inhalation Powder: Pediatric First Approval
AFREZZA® (人胰岛素) 吸入粉剂:儿科首次批准
Pediatric Drugs
IF
3.3
2026-08-18
0
PRE
AI
Sheridan M. Hoy
分享
收藏
Novel Agents on the Therapeutic Horizon For Paediatric Inflammatory Bowel Diseases: An Analysis of Clinical Trials Registries
儿科炎症性肠病治疗新药展望:临床 trials 注册分析
Pediatric Drugs
IF
3.3
2026-08-13
0
OA
AI
Dhruv Gupte; Nidhi Rashmikant Suthar; John K. MacDonald; Jessica Le; Ruben J. Colman; Brian G. Feagan; Camilyn Cheng; Jurij Hanzel; Christopher Ma; Vipul Jairath; Eileen Crowley
分享
收藏
Ocrelizumab: Pediatric First Approval
奥法妥木单抗:儿科首次批准
Pediatric Drugs
IF
3.3
2026-08-07
0
PRE
AI
Sheridan M. Hoy
分享
收藏
21‑Valent Pneumococcal Conjugate Vaccine V116 (CAPVAXIVE®): Pediatric First Approval
21价肺炎球菌结合疫苗V116(CAPVAXIVE®):儿科首次获批
Pediatric Drugs
IF
3.3
2026-07-27
0
PRE
AI
Matt Shirley
分享
收藏